Patents by Inventor Oleksandr Balakin

Oleksandr Balakin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210187016
    Abstract: A method for preventing or treating Nonalcoholic steatohepatitis (NASH) comprising administering a prophylactically or therapeutically effective amount of 64Zn-enriched zinc. The 64Zn-enriched zinc is in the form of a 64Zne (64Zn enriched) compound or a 64Zne salt. In certain embodiments, the disclosed compositions contain zinc that is at least 80% 64Zne, at least 90% 64Zne, at least 95% 64Zne, or at least 99% 64Zne, for example, zinc that is 80% 64Zne, 85% 64Zne, 90% 64Zne, 95% 64Zne, 99% 64Zne, or 99.9% 64Zne.
    Type: Application
    Filed: December 20, 2019
    Publication date: June 24, 2021
    Applicant: Vector Vitale IP LLC
    Inventors: Peter NOVAK, Maxim TEMNIKOV, Oleksandr BALAKIN
  • Publication number: 20210154337
    Abstract: A method for treating melanoma or preventing the development of melanoma comprising administration of a composition comprising 64Zne(Asp)2 in a therapeutically effective amount. Such administration may be via injection such as intratumoral and/or intravenous injection and may be once a day or more than once a day. A composition for the treatment of or prevention of melanoma comprising 64Zne(Asp)2 in a therapeutically effective amount. The composition may be a liquid suitable for injection.
    Type: Application
    Filed: November 22, 2019
    Publication date: May 27, 2021
    Applicant: Vector Vitale IP LLC
    Inventors: Peter NOVAK, Maxim TEMNIKOV, Oleksandr BALAKIN
  • Publication number: 20210093663
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Application
    Filed: December 7, 2020
    Publication date: April 1, 2021
    Applicant: Vector Vitale IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Patent number: 10933091
    Abstract: A method of treating type I diabetes comprising administering a therapeutically effective amount of 64Zn-enriched zinc.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: March 2, 2021
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Patent number: 10857180
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Grant
    Filed: December 29, 2018
    Date of Patent: December 8, 2020
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Y Novak, Maxim V Temnikov, Oleksandr Balakin
  • Patent number: 10799530
    Abstract: A method for reducing the weight of an overweight or obese subject comprising administering a therapeutically effective amount of a composition comprising 64Zn-enriched zinc. A method for preventing or reducing weight gain comprising administering an effective amount of a composition comprising 64Zn-enriched zinc.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: October 13, 2020
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Publication number: 20200000845
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Application
    Filed: December 29, 2018
    Publication date: January 2, 2020
    Inventors: Peter Y Novak, Maxim V Temnikov, Oleksandr Balakin
  • Publication number: 20190105345
    Abstract: An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of 1H, 12C, 16O, 14N, 39K, 24Mg, 64Zn, 85Rb, 28Si, 54Fe, 92Mo, 74Se, 58Ni, 70Ge, 52Cr, 63Cu, 50V, or combinations thereof, wherein the composition is enriched for the at least one light isotope. A method of treating and preventing bacterial diseases in humans and non-human animals by administering the composition. The use of the said composition in human and veterinary medicine for the prevention and treatment of diseases in humans and non-human animals and also as an antiseptic and disinfectant.
    Type: Application
    Filed: December 5, 2018
    Publication date: April 11, 2019
    Inventors: Peter Y. Novak, Maxim V. Temnikov, Oleksandr Balakin
  • Patent number: 10226484
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: March 12, 2019
    Inventors: Peter Y Novak, Maxim V Temnikov, Oleksandr Balakin
  • Patent number: 10183041
    Abstract: An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of 1H, 12C, 16O, 14N, 39K, 24Mg, 64Zn, 85Rb, 28Si, 54Fe, 92Mo, 74Se, 58Ni, 70Ge, 52Cr, 63Cu, 50V, or combinations thereof, wherein the composition is enriched for the at least one light isotope. A method of treating and preventing bacterial diseases in humans and non-human animals by administering the composition. The use of the said composition in human and veterinary medicine for the prevention and treatment of diseases in humans and non-human animals and also as an antiseptic and disinfectant.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: January 22, 2019
    Assignee: VECTOR VITALE IP LLC
    Inventors: Peter Y Novak, Maxim V Temnikov, Oleksandr Balakin
  • Publication number: 20180296596
    Abstract: An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of 1H, 12C, 16O, 14N, 39K, 24Mg, 64Zn, 85Rb, 28Si, 54Fe, 92Mo, 74Se, 58Ni, 70Ge, 52Cr, 63Cu, 50V, or combinations thereof, wherein the composition is enriched for the at least one light isotope. A method of treating and preventing bacterial diseases in humans and non-human animals by administering the composition. The use of the said composition in human and veterinary medicine for the prevention and treatment of diseases in humans and non-human animals and also as an antiseptic and disinfectant.
    Type: Application
    Filed: April 12, 2017
    Publication date: October 18, 2018
    Inventors: Peter Y. Novak, Maxim V. Temnikov, Oleksandr Balakin
  • Publication number: 20180055879
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Application
    Filed: June 2, 2017
    Publication date: March 1, 2018
    Inventors: Peter Y. Novak, Maxim V Temnikov, Oleksandr Balakin
  • Patent number: 9861659
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Grant
    Filed: August 23, 2015
    Date of Patent: January 9, 2018
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Y Novak, Maxim V Temnikov, Oleksandr Balakin
  • Publication number: 20160151415
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Application
    Filed: August 23, 2015
    Publication date: June 2, 2016
    Inventors: Peter Y. Novak, Maxim V. Temnikov, Oleksandr Balakin
  • Publication number: 20160153957
    Abstract: A method of the present invention is used for diagnostics of pathology in biological objects. The method includes the steps of analyzing a first biological element obtained from a human to identify ratio between first isotopes and second isotopes wherein weight of the first isotopes differs from weight of the second isotopes. The method further includes the step of analyzing information about natural distribution of the first isotopes and the second isotopes in a second biological element. The method includes the step of comparing the ratio of the first isotopes and the second isotopes of the first biological element with the ratio of the first isotopes and the second isotopes of the second biological element thereby changing the ratio of the first isotopes and the second isotopes of the first biological element to match the ratio of the first isotopes and the second isotopes of the second biological element.
    Type: Application
    Filed: August 23, 2015
    Publication date: June 2, 2016
    Inventors: Peter Y. Novak, Maxim V. Temnikov, Oleksandr Balakin